IBDEI0PO ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34013,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Bilateral Legs
 ;;^UTILITY(U,$J,358.3,34013,1,4,0)
 ;;=4^I70.263
 ;;^UTILITY(U,$J,358.3,34013,2)
 ;;=^5007605
 ;;^UTILITY(U,$J,358.3,34014,0)
 ;;=I70.262^^100^1494^11
 ;;^UTILITY(U,$J,358.3,34014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34014,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Left Leg
 ;;^UTILITY(U,$J,358.3,34014,1,4,0)
 ;;=4^I70.262
 ;;^UTILITY(U,$J,358.3,34014,2)
 ;;=^5007604
 ;;^UTILITY(U,$J,358.3,34015,0)
 ;;=I70.261^^100^1494^12
 ;;^UTILITY(U,$J,358.3,34015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34015,1,3,0)
 ;;=3^Athscl Natv Arteries of Extrm w/ Gangrene,Right Leg
 ;;^UTILITY(U,$J,358.3,34015,1,4,0)
 ;;=4^I70.261
 ;;^UTILITY(U,$J,358.3,34015,2)
 ;;=^5007603
 ;;^UTILITY(U,$J,358.3,34016,0)
 ;;=I71.2^^100^1494^20
 ;;^UTILITY(U,$J,358.3,34016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34016,1,3,0)
 ;;=3^Thoracic Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,34016,1,4,0)
 ;;=4^I71.2
 ;;^UTILITY(U,$J,358.3,34016,2)
 ;;=^5007787
 ;;^UTILITY(U,$J,358.3,34017,0)
 ;;=I71.4^^100^1494^1
 ;;^UTILITY(U,$J,358.3,34017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34017,1,3,0)
 ;;=3^Abdominal Aortic Aneurysm w/o Rupture
 ;;^UTILITY(U,$J,358.3,34017,1,4,0)
 ;;=4^I71.4
 ;;^UTILITY(U,$J,358.3,34017,2)
 ;;=^5007789
 ;;^UTILITY(U,$J,358.3,34018,0)
 ;;=I73.9^^100^1494^19
 ;;^UTILITY(U,$J,358.3,34018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34018,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34018,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,34018,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,34019,0)
 ;;=I82.891^^100^1494^14
 ;;^UTILITY(U,$J,358.3,34019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34019,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Chronic
 ;;^UTILITY(U,$J,358.3,34019,1,4,0)
 ;;=4^I82.891
 ;;^UTILITY(U,$J,358.3,34019,2)
 ;;=^5007939
 ;;^UTILITY(U,$J,358.3,34020,0)
 ;;=I82.890^^100^1494^13
 ;;^UTILITY(U,$J,358.3,34020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34020,1,3,0)
 ;;=3^Embolism/Thrombosis Oth Spec Veins,Acute
 ;;^UTILITY(U,$J,358.3,34020,1,4,0)
 ;;=4^I82.890
 ;;^UTILITY(U,$J,358.3,34020,2)
 ;;=^5007938
 ;;^UTILITY(U,$J,358.3,34021,0)
 ;;=E78.0^^100^1495^12
 ;;^UTILITY(U,$J,358.3,34021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34021,1,3,0)
 ;;=3^Pure Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,34021,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,34021,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,34022,0)
 ;;=E78.1^^100^1495^13
 ;;^UTILITY(U,$J,358.3,34022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34022,1,3,0)
 ;;=3^Pure Hyperglyceridemia
 ;;^UTILITY(U,$J,358.3,34022,1,4,0)
 ;;=4^E78.1
 ;;^UTILITY(U,$J,358.3,34022,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,34023,0)
 ;;=E78.2^^100^1495^11
 ;;^UTILITY(U,$J,358.3,34023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34023,1,3,0)
 ;;=3^Mixed Hyperlipidemia
 ;;^UTILITY(U,$J,358.3,34023,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,34023,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,34024,0)
 ;;=I10.^^100^1495^3
 ;;^UTILITY(U,$J,358.3,34024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34024,1,3,0)
 ;;=3^Essential Primary Hypertension
 ;;^UTILITY(U,$J,358.3,34024,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,34024,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,34025,0)
 ;;=I11.9^^100^1495^10
 ;;^UTILITY(U,$J,358.3,34025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34025,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,34025,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,34025,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,34026,0)
 ;;=I11.0^^100^1495^9
 ;;^UTILITY(U,$J,358.3,34026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34026,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,34026,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,34026,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,34027,0)
 ;;=I12.0^^100^1495^8
 ;;^UTILITY(U,$J,358.3,34027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34027,1,3,0)
 ;;=3^Hypertensive Chr Kidney Disease w/ ESRD
 ;;^UTILITY(U,$J,358.3,34027,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,34027,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,34028,0)
 ;;=I13.10^^100^1495^6
 ;;^UTILITY(U,$J,358.3,34028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34028,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,34028,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,34028,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,34029,0)
 ;;=I13.0^^100^1495^4
 ;;^UTILITY(U,$J,358.3,34029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34029,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,34029,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,34029,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,34030,0)
 ;;=I13.11^^100^1495^7
 ;;^UTILITY(U,$J,358.3,34030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34030,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/o Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,34030,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,34030,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,34031,0)
 ;;=I13.2^^100^1495^5
 ;;^UTILITY(U,$J,358.3,34031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34031,1,3,0)
 ;;=3^HTN Hrt & Chr Kdny Dis w/ Hrt Fail w/ Stg 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,34031,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,34031,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,34032,0)
 ;;=I48.91^^100^1495^1
 ;;^UTILITY(U,$J,358.3,34032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34032,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,34032,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,34032,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,34033,0)
 ;;=I48.92^^100^1495^2
 ;;^UTILITY(U,$J,358.3,34033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34033,1,3,0)
 ;;=3^Atrial Flutter,Unspec
 ;;^UTILITY(U,$J,358.3,34033,1,4,0)
 ;;=4^I48.92
 ;;^UTILITY(U,$J,358.3,34033,2)
 ;;=^5007230
 ;;^UTILITY(U,$J,358.3,34034,0)
 ;;=B07.9^^100^1496^288
 ;;^UTILITY(U,$J,358.3,34034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34034,1,3,0)
 ;;=3^Viral Wart,Unspec
 ;;^UTILITY(U,$J,358.3,34034,1,4,0)
 ;;=4^B07.9
 ;;^UTILITY(U,$J,358.3,34034,2)
 ;;=^5000519
 ;;^UTILITY(U,$J,358.3,34035,0)
 ;;=A63.0^^100^1496^34
 ;;^UTILITY(U,$J,358.3,34035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34035,1,3,0)
 ;;=3^Anogenital (Venereal) Warts
 ;;^UTILITY(U,$J,358.3,34035,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,34035,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,34036,0)
 ;;=B35.0^^100^1496^279
 ;;^UTILITY(U,$J,358.3,34036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34036,1,3,0)
 ;;=3^Tinea Barbae and Tinea Capitis
 ;;^UTILITY(U,$J,358.3,34036,1,4,0)
 ;;=4^B35.0
 ;;^UTILITY(U,$J,358.3,34036,2)
 ;;=^5000604
 ;;^UTILITY(U,$J,358.3,34037,0)
 ;;=B35.1^^100^1496^284
 ;;^UTILITY(U,$J,358.3,34037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34037,1,3,0)
 ;;=3^Tinea Unguium
 ;;^UTILITY(U,$J,358.3,34037,1,4,0)
 ;;=4^B35.1
 ;;^UTILITY(U,$J,358.3,34037,2)
 ;;=^119748
 ;;^UTILITY(U,$J,358.3,34038,0)
 ;;=B35.6^^100^1496^281
 ;;^UTILITY(U,$J,358.3,34038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34038,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,34038,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,34038,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,34039,0)
 ;;=B35.3^^100^1496^283
 ;;^UTILITY(U,$J,358.3,34039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34039,1,3,0)
 ;;=3^Tinea Pedis
 ;;^UTILITY(U,$J,358.3,34039,1,4,0)
 ;;=4^B35.3
 ;;^UTILITY(U,$J,358.3,34039,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,34040,0)
 ;;=B35.5^^100^1496^282
 ;;^UTILITY(U,$J,358.3,34040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34040,1,3,0)
 ;;=3^Tinea Imbricata
 ;;^UTILITY(U,$J,358.3,34040,1,4,0)
 ;;=4^B35.5
 ;;^UTILITY(U,$J,358.3,34040,2)
 ;;=^119725
 ;;^UTILITY(U,$J,358.3,34041,0)
 ;;=B35.4^^100^1496^280
 ;;^UTILITY(U,$J,358.3,34041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34041,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,34041,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,34041,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,34042,0)
 ;;=B35.8^^100^1496^137
 ;;^UTILITY(U,$J,358.3,34042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34042,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,34042,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,34042,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,34043,0)
 ;;=B36.9^^100^1496^272
 ;;^UTILITY(U,$J,358.3,34043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34043,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,34043,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,34043,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,34044,0)
 ;;=D69.0^^100^1496^32
 ;;^UTILITY(U,$J,358.3,34044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34044,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,34044,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,34044,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,34045,0)
 ;;=B00.9^^100^1496^158
 ;;^UTILITY(U,$J,358.3,34045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34045,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,34045,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,34045,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,34046,0)
 ;;=B02.9^^100^1496^291
 ;;^UTILITY(U,$J,358.3,34046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34046,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,34046,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,34046,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,34047,0)
 ;;=D17.9^^100^1496^89
 ;;^UTILITY(U,$J,358.3,34047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34047,1,3,0)
 ;;=3^Benign Lipomatous Neop,Unspec
 ;;^UTILITY(U,$J,358.3,34047,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,34047,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,34048,0)
 ;;=E08.621^^100^1496^134
 ;;^UTILITY(U,$J,358.3,34048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34048,1,3,0)
 ;;=3^DM d/t Underlying Condition w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,34048,1,4,0)
 ;;=4^E08.621
